Trial Outcomes & Findings for COronary and MICrocirculatory Measurements in Patients With Aortic Valve Stenosis. (NCT NCT04420325)

NCT ID: NCT04420325

Last Updated: 2025-09-05

Results Overview

Aortic valve intervention can potentially result in a change in fractional flow reserve (FFR) 6 months after SAVR/TAVI. FFR is the ratio of two intra-coronary measurements (Distal coronary pressure divided by proximal coronary pressure) and can range from 0.0-1.0. A lower FFR means that the lesion is more severe and therefore a higher FFR is considered better. The threshold to speak about hemodynamic significant of a lesion is 0.80. If the lesion has an FFR of ≤ 0.80 means the lesions is significant and treatment is necessary.

Recruitment status

COMPLETED

Target enrollment

116 participants

Primary outcome timeframe

6 months

Results posted on

2025-09-05

Participant Flow

Participant milestones

Participant milestones
Measure
Entire Study Population
Patients with AS undergoing TAVI or SAVR
Overall Study
STARTED
116
Overall Study
COMPLETED
84
Overall Study
NOT COMPLETED
32

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

COronary and MICrocirculatory Measurements in Patients With Aortic Valve Stenosis.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Entire Study Population
n=116 Participants
Patients with AS undergoing TAVI or SAVR
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=5 Participants
Age, Categorical
>=65 years
110 Participants
n=5 Participants
Age, Continuous
79.48 years
STANDARD_DEVIATION 8.18 • n=5 Participants
Sex: Female, Male
Female
47 Participants
n=5 Participants
Sex: Female, Male
Male
69 Participants
n=5 Participants
Race/Ethnicity, Customized
White
116 Participants
n=5 Participants
Region of Enrollment
Belgium
116 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months

Aortic valve intervention can potentially result in a change in fractional flow reserve (FFR) 6 months after SAVR/TAVI. FFR is the ratio of two intra-coronary measurements (Distal coronary pressure divided by proximal coronary pressure) and can range from 0.0-1.0. A lower FFR means that the lesion is more severe and therefore a higher FFR is considered better. The threshold to speak about hemodynamic significant of a lesion is 0.80. If the lesion has an FFR of ≤ 0.80 means the lesions is significant and treatment is necessary.

Outcome measures

Outcome measures
Measure
Entire Study Population
n=116 Participants
Patients with AS undergoing TAVI or SAVR
FFR 6 Months After SAVR/TAVI.
-0.0279 ratio
Standard Deviation 0.0368

SECONDARY outcome

Timeframe: 6 months

Measurement of IMR in patients with AS prior to intervention and 6 months after TAVI/SAVR. IMR is unitless and gives a description of coronary microvascular resistance, it can range from 0-100. Lower values are considered better as they are related with better microvascular function and health. If the IMR \> 25 we say microvascular dysfunction is present and treatment is considered necessary.

Outcome measures

Outcome measures
Measure
Entire Study Population
n=116 Participants
Patients with AS undergoing TAVI or SAVR
IMR 6 Months After SAVR/TAVI.
-2.8150 Unitless
Standard Deviation 12.1600

SECONDARY outcome

Timeframe: Baseline

Comparison of the diagnostic performance of FFR versus RFR compared with SPECT ischemia. The higher the Area under the curve the better. The range is 0.0-1.0. An area under the curve for a ROC model is considered excellent if \> 0.8.

Outcome measures

Outcome measures
Measure
Entire Study Population
n=116 Participants
Patients with AS undergoing TAVI or SAVR
FFR Versus RFR to Determine Ischemia.
0.8719 probability
Interval 0.804 to 0.9397

Adverse Events

Entire Study Population

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lennert Minten

UZ Leuven

Phone: +32496397568

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place